Greater weight loss promised by higher-dose Wegovy shot, now approved by FDA
“Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market.”
Balazs called the higher dosage a “major jump,” noting that the incidences of stomach- and skin-related side effects at this higher dose are “meaningful.”
CLICK HERE FOR MORE HEALTH STORIES
“This approval is for obesity management, not diabetes treatment,” the expert emphasized. “For patients with type 2 diabetes, currently approved semaglutide dosing remains lower unless the primary treatment goal is weight loss under the obesity indication.”
Fox News Digital reached out to the FDA for comment.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
Article source: https://www.foxnews.com/health/greater-weight-loss-promised-higher-dose-wegovy-shot-now-approved-fda